Literature DB >> 1845899

Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells.

B A Antoni1, A B Rabson, I L Miller, J P Trempe, N Chejanovsky, B J Carter.   

Abstract

The adeno-associated virus (AAV) rep gene encodes four proteins (Rep78, Rep68, Rep52, and Rep40) required for AAV DNA replication and AAV gene regulation. In addition, the Rep proteins may have pleiotropic regulatory effects in heterologous systems, and in particular Rep78 may mediate a negative regulatory effect. We analyzed the effects of the AAV rep gene on human immunodeficiency virus type 1 (HIV-1) gene expression. The rep gene proteins of AAV type 2 (AAV2) inhibited the trans-activating ability of HIV-1. Constructs containing the AAV2 rep gene (pHIVrep) or a CAT gene (pBennCAT) expressed from the 5' HIV-1 long terminal repeat were inducible for Rep78 and Rep68 or CAT expression, respectively, when cotransfected with a plasmid containing the HIV-1 tat gene (pARtat). When equivalent amounts of pHIVrep and pBennCAT were cotransfected with increasing amounts of pARtat, expression of CAT activity was decreased. The pHIVrep construct was more inhibitory than plasmids expressing rep from the wild-type AAV2 p5 transcription promoter. rep expression from pHIVrep almost completely inhibited the replication of an HIV-1 proviral clone as measured by reverse transcriptase activity and p24 protein levels. Inhibition of HIV-1 production by Rep protein was also seen at the transcriptional level in that all HIV-1 transcripts were decreased when pHIVrep was present. The inhibitory effects of pHIVrep appear to be mediated primarily by Rep78 and perhaps Rep68. These results suggest that a trans-acting protein from a heterologous virus might be used to inhibit HIV-1 growth.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845899      PMCID: PMC240530     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Strategies for antiviral therapy in AIDS.

Authors:  H Mitsuya; S Broder
Journal:  Nature       Date:  1987 Feb 26-Mar 4       Impact factor: 49.962

Review 2.  Regulatory pathways governing HIV-1 replication.

Authors:  B R Cullen; W C Greene
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

3.  Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

Authors:  J Sodroski; R Patarca; C Rosen; F Wong-Staal; W Haseltine
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

Review 4.  Mysteries of HIV: challenges for therapy and prevention.

Authors:  J A Levy
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

5.  The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus.

Authors:  P L Hermonat
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

6.  Factors that bind to adeno-associated virus terminal repeats.

Authors:  D S Im; N Muzyczka
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

7.  Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor.

Authors:  N Chejanovsky; B J Carter
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

8.  Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants.

Authors:  P L Hermonat; M A Labow; R Wright; K I Berns; N Muzyczka
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

9.  Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.

Authors:  H E Gendelman; W Phelps; L Feigenbaum; J M Ostrove; A Adachi; P M Howley; G Khoury; H S Ginsberg; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.

Authors:  F K Wu; J A Garcia; D Harrich; R B Gaynor
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  42 in total

1.  Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins.

Authors:  J Wu; M D Davis; R A Owens
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  The adeno-associated virus type 2 Rep protein regulates RNA processing via interaction with the transcription template.

Authors:  Jianming Qiu; David J Pintel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  PKA/PrKX activity is a modulator of AAV/adenovirus interaction.

Authors:  Giovanni Di Pasquale; John A Chiorini
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

4.  How adeno-associated virus Rep78 protein arrests cells completely in S phase.

Authors:  Carole Berthet; Kenneth Raj; Philippe Saudan; Peter Beard
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

5.  In vitro resolution of adeno-associated virus DNA hairpin termini by wild-type Rep protein is inhibited by a dominant-negative mutant of rep.

Authors:  R A Owens; B J Carter
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Adeno-associated virus type 2 modulates the host DNA damage response induced by herpes simplex virus 1 during coinfection.

Authors:  Rebecca Vogel; Michael Seyffert; Regina Strasser; Anna P de Oliveira; Christiane Dresch; Daniel L Glauser; Nelly Jolinon; Anna Salvetti; Matthew D Weitzman; Mathias Ackermann; Cornel Fraefel
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

7.  Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products.

Authors:  K A Vincent; S T Piraino; S C Wadsworth
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.

Authors:  S R Kyöstiö; R S Wonderling; R A Owens
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein.

Authors:  D M McCarty; D J Pereira; I Zolotukhin; X Zhou; J H Ryan; N Muzyczka
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Interaction of wild-type and mutant adeno-associated virus (AAV) Rep proteins on AAV hairpin DNA.

Authors:  M D Weitzman; S R Kyöstiö; B J Carter; R A Owens
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.